Display options
Share it on

World J Stem Cells. 2019 Jan 26;11(1):44-54. doi: 10.4252/wjsc.v11.i1.44.

Regenerative potential of mouse embryonic stem cell-derived PDGFRα.

World journal of stem cells

Seon Pyo Hong, Sukhyun Song, Seungjoo Lee, Hyeonju Jo, Hyoung Kyu Kim, Jin Han, Jae-Hyeong Park, Sung Woo Cho

Affiliations

  1. Center for Vascular Research, Institute of Basic Science (IBS), Daejeon 34141, South Korea.
  2. Department of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, South Korea.
  3. Cardiovascular and Metabolic Disease Center, Department of Physiology, Department of Health Sciences and Technology, BK21 plus Project Team, Inje University College of Medicine, Busan 47392, South Korea.
  4. Department of Cardiology in Internal Medicine, School of Medicine, Chungnam National University Hospital, Chungnam National University, Daejeon 35015, South Korea.
  5. Division of Cardiology, Department of Internal Medicine, Inje University College of Medicine, Seoul Paik Hospital, Seoul 04551, South Korea.

PMID: 30705714 PMCID: PMC6354102 DOI: 10.4252/wjsc.v11.i1.44

Abstract

BACKGROUND: Pluripotent stem cell-derived cardiomyocytes (CMs) have become one of the most attractive cellular resources for cell-based therapy to rescue damaged cardiac tissue.

AIM: We investigated the regenerative potential of mouse embryonic stem cell (ESC)-derived platelet-derived growth factor receptor-α (DGFRα)

METHODS: We induced mouse ESCs into PDGFRα

RESULTS: Compared with the untreated MI hearts, the anterior and septal regional wall motion and systolic functional parameters were notably and similarly improved in the MI hearts implanted with PDGFRα

CONCLUSION: PDGFRα

Keywords: Cardiomyocyte; Embryonic stem cell; Myocardial infarction; Pluripotent stem cell; Regeneration

Conflict of interest statement

Conflict-of-interest statement: No potential conflicts of interest relevant to this article were reported.

References

  1. Blood. 2003 Feb 1;101(3):886-93 - PubMed
  2. FASEB J. 2005 Sep;19(11):1534-6 - PubMed
  3. Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):192-7 - PubMed
  4. Nature. 2008 Feb 21;451(7181):937-42 - PubMed
  5. Nature. 2008 May 15;453(7193):322-9 - PubMed
  6. Stem Cells. 2013 May;31(5):829-37 - PubMed
  7. J Am Heart Assoc. 2014 Mar 13;3(2):e000693 - PubMed
  8. Nature. 2014 Jun 12;510(7504):273-7 - PubMed
  9. Stem Cell Reports. 2015 Nov 10;5(5):753-762 - PubMed
  10. Cell Stem Cell. 2016 Mar 3;18(3):354-67 - PubMed
  11. Cell Stem Cell. 2016 Mar 3;18(3):368-81 - PubMed
  12. Cell Rep. 2016 Jul 26;16(4):1026-1038 - PubMed
  13. JCI Insight. 2016 Jul 7;1(10): - PubMed
  14. Sci Rep. 2016 Aug 19;6:31457 - PubMed
  15. Stem Cells. 2016 Dec;34(12):2875-2888 - PubMed
  16. Nature. 2016 Oct 20;538(7625):388-391 - PubMed
  17. Sci Rep. 2017 Feb 06;7:41840 - PubMed
  18. Trends Mol Med. 2017 Jul;23(7):651-668 - PubMed
  19. Circ Res. 2017 Sep 1;121(6):e22-e36 - PubMed
  20. Stem Cell Reports. 2017 Nov 14;9(5):1415-1422 - PubMed
  21. Circulation. 2018 Apr 17;137(16):1712-1730 - PubMed
  22. Stem Cell Reports. 2018 Jan 9;10(1):87-100 - PubMed
  23. Cell Rep. 2018 Jan 9;22(2):546-556 - PubMed
  24. Stem Cell Reports. 2018 Mar 13;10(3):848-859 - PubMed
  25. Nat Biotechnol. 2018 Aug;36(7):597-605 - PubMed
  26. Exp Hematol. 1994 Sep;22(10):979-84 - PubMed
  27. J Virol. 1998 Nov;72(11):8463-71 - PubMed

Publication Types